Astera Labs, Inc. Common Stock
NASDAQ:ALABSemiconductors
+$39.44 today
- Market cap
- $37.88B
- Beta
- 3.96
- P/E (TTM)
- 264.2
- EPS (TTM)
- $1.57
Volume 4.57M
Average 5.72M
ALAB Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Astera Labs, Inc. Common StockNASDAQ: ALAB
Other Current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Other current liabilities rises 100.1% from a year ago
Other current liabilities stood at $85.8M at the end of Q2 FY2026, up 100.1% from a year earlier and up 110.5% from the prior quarter. Over 3 fiscal years it compounded at +110.6% a year.
Context
- Other current liabilities amounted to 4.4% of total assets at the end of Q2 FY2026, up 1.1 pp from a year earlier.
- Other current liabilities increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +100.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 90.68M USD
- Year-over-year change
- +139.1%
- 3-year CAGR
- +110.6%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90.68M | +139.1% |
| FY2024 | 2024-12-31 | 37.92M | +225.1% |
| FY2023 | 2023-12-31 | 11.66M | +20.1% |
| FY2022 | 2022-12-31 | 9.71M | — |
Other Current Liabilities vs competitors
How ALAB compares with its peers on the latest reported figures
- ALAB's Jun 2026 other current liabilities of $85.8M is the 4th highest of the 7 companies compared; the peer median is $435.31M.
- Its year-over-year change of +100.1% is the 3rd highest of 5, against a peer median of +49.7%.
- Other current liabilities amounts to 4.4% of total assets for ALAB, versus a peer median of 3.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Aug 2026 | $2.16B | — | +0.2% | 4.5% | |
| Aug 2026 | $1.15B | +409.8% | -5.4% | 4.2% | |
| Sep 2026 | $795M | -23.3% | +15.9% | 2.2% | |
| Jun 2026 | $85.8M | +100.1% | +110.6% | 4.4% | |
| Aug 2026 | $75.61M | +122.7% | +116.4% | 2.5% | |
| Sep 2026 | $63.1M | -37.1% | -23.9% | 6.9% | |
| Jun 2026 | $0 | — | +10.7% | 0.0% | |
| Peer median (excluding ALAB) | $435.31M | +49.7% | +5.5% | 3.3% | |
Competitors are the stored peer set for ALAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Astera Labs, Inc. Common Stock
NASDAQ:ALAB
Intrinsic Alpha fair value
Locked
Current Price
$216.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.